Psychical and psychological factors and functional gastrointestinal diseases

World Chinese Journal of Digestology

Volumn 10, Issue 11, 2002, Pages 1324-1328

  Zhang, W W ^a   Li, Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONSTIPATION; DEPRESSION; DISEASE SEVERITY; DYSPEPSIA; GASTROINTESTINAL DISEASE; HUMAN; IRRITABLE COLON; MENTAL DISEASE; PSYCHOLOGICAL ASPECT; SHORT SURVEY;

EID: 0036859369     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (102)

1. Drossman DA, Corazziari E, Talley NJ. Rome II: A multinational consensus document on functional gastrointestinal disorders. Gut 1999;45(suppl II):II 1-II 81
2. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, Richter JE, Koch GG. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580
3. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225-235
4. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736-1741
5. Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Scand J Gastroenterol 1997;32:1083-1089
6. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000; 95:67-71
7. Gralnek I, Hays R, Kilbourne A, Naliboff B, Mayer E. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-660
8. Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, Guthrie E, Read N, Thompson D. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 2001;134:860-868
9. Lea R, Whorwell PJ. Quality of life in irritable bowel syndrome. Pharmacoeconomics 2001;19:643-653
10. Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-ralated quality of life in functional GI disorders: Focus on constipation and resource utilization. Am J Gastroenterol 2002;97: 1986-1993
11. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45(suppl II):II 1-II 5
12. Kamm MA. The role of psychosocial factors in functional gut disease. Eur J Surg 1998;Suppl 583:37-40
13. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999;45 (Suppl 2):II25-30
14. Olden KW, Drossman DA. Psychologic and psychiatric aspects of gastrointestinal disease. Med Clin Nor Am 2000;84:1313-1327
15. Drossman DA. Gastrointestinal illness and the biopsychosocial model. Psychosom Med 1998;60:258-267
16. Aziz Q, Thompson WG. Brain-gut axis in health and disease. Gastroenterology 1998;114:559-578
17. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, Diaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: Comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155-1161
18. Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Dig Dis Sci 1993;38:1581-1589
19. Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in random population: Prevalence, incidence, natural history and risk factors. J Intern Med 1994;236:23-30
20. Muller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, Muris IW, Oberndorff-Klein Wolthuis A, Pace F, Rodrigo L, Stockbrugger R, Vatn MH. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion 2001;64:200-204
21. Walker EA, Roy-Byrne PP, Katon WJ. Irritable bowel syndrome and psychiatric illness. Am J Psychiatry 1990;147:565-572
22. Schwarz SP, Blanchard EB, Berreman CF, Scharff L, Taylor AE, Greene BR, Suls JM, Malamood HS. Psychological aspects of irritable bowel syndrome: Comparisons with inflammatory bowel disease and nonpatient controls. Behav Res Ther 1993;31:297-304
23. Kaplan DS, Masand PS, Gupta S. The relationship of irritable bowel syndrome (IBS) and panic disorder. Ann Clin Psychiatry 1996;8:81-88
24. Masand PS, Kaplan DS, Gupta S, Bhandary AN, Nasra GS, Kline MD, Margo KL. Major depression and irritable bowel syndrome: Is there a relationship? J Clin Psychiatry 1995;56:363-367
25. Masand PS, Kaplan DS, Gupta S, Bhandary AN. Irritable bowel syndrome and dysthymia: Is there a relationship? Psychosomatics 1997;38: 63-69
26. Drossman DA, Whitehead WE, Toner BB, Diamant N, Hu YJ, Bangdiwala SI, Jia H. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 2000;95:974-980
27. Lydiard RB. Irritable bowel syndrome, anxiety, and depression: What are the links? J Clin Psychiatry 2001;62(suppl 8):38-45
28. Gibbs-Gallagher N, Palsson OS, Levy RL, Meyer K, Drossman DA, Whitehead WE. Selective call of gastrointestinal-sensation word: Evidence for a cognitivebehavioral contribution to irritable bowel syndrome. Am J Gastroenterol 2001;96:1133-1138
29. Locke GR. Prevalence, incidence and natural history of dyspepsia and functional dyspepsia. Baillieres Clin Gastroenterol 1998;12:435-442
30. Haug TT, Svebak S, Wilhelmsen I, Berstad A, Ursin H. Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosom Res 1994;38:281-291
31. Haug TT, Wilhelmsen I, Ursin H, Berstad A. What are the real problems for patients with functional dyspepsia? Scand J Gastroenterol 1995;30:97-100
32. Haug TT, Wilhelmsen I, Berstad A, Ursin H. Life events and stress in patients with functional dyspepsia compared with patients with duodenal ulcer and healthy controls. Scand J Gastroenterol 1995;30:524-530
33. Walker EA, Katon WJ, Jemelka RP, Roy-Bryne PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the epidemiologic catchment area(ECA) study. Am J Med 1992;92 (1A):26s-30s
34. Haug TT, Mykletun A, Dahl AA. Are anxiety and depression related to gastrointestinal symptoms in the general population? Scand J Gastroenterol 2002;37:294-298
35. Bennett EJ, Evans P, Scott AM, Badcock CA, Shuter B, Hoschl R, Tennant CC, Kellow JE. Psychological and sex feature of delayed gut transit in functional gustrointestinal disorders. Gut 2000;46:83-87
36. Johnston BT, Lewis SA, Love AH. Psychological factors in gastrooesophageal reflux disease. Gut 1995;36:481-482
37. Ho KY, Kang JY, Yeo B, Ng WL. Non-cardiac, non-oesophageal chest pain: The relevance of psychological factors. Gut 1998;43:105-110
38. Sperber AD, Drossman DA. Chronic Functional abdominal Pain (CFAP). Curr Treat Options Gastroenterol 2000;3:315-328
39. Tanum L, Malt UF. Personality traits predict treatment outcome with an antidepressant in patients with functional gastrointestinal disorder. Scand J Gastroenterol 2000;35:935-941
40. Tanum L, Malt UF. Personality and physical symptoms in nonpsychiatric patients with functional gastrointestinal disorder. J Psychosom Res 2001;50:139-146
41. Stam R, Skkermans LMA, Wiegant VM. Trauma and the gut: Interactions between stressful experience and intestinal function. Gut 1997;40:704-709
42. Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE. Functional gastrointestinal disorders: Psychological, social, and somatic features. Gut 1998;42:414-420
43. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: Subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut 1992;33:825-830
44. Longstreth GF. Bowel patterns and anxiety. Demographic factors. J Clin Gastroenterol 1993;17:128-132
45. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology 1995;109:1772-1780
46. Jarrett M, Heitkemper M, Cain KC, Tuftin M, Walker EA, Bond EF, Levy RL. The relationship between psychological distress and gastrointestinal symptoms in women with irritable bowel syndrome. Nurs Res 1998;47:154-161
47. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, Underwood JE, Read NW. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-406
48. Pinto C, Lele MV, Joglekar AS, Panwar VS, Dhavale HS. Stressful life-events, anxiety, depression and coping in patients of irritable bowel syndrome. J Assoc Physicians India 2000;48:589-593
49. Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 1995;25:1259-1267
50. Drossman DA. Irritable bowel syndrome and sexual/physical abuse history. Eur J Gastroenterol Hepatol 1997;9:327-330
51. Delvaux M, Denis P, Allemand H. Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Eur J Gastroenterol Hepatol 1997;9:345-352
52. Drossman DA. Sexual and physical abuse and gastrointestinal illness. Scand J Gastroenterol (Suppl) 1995;208:90-96
53. Blanchard EB, Keefer L, Payne A, Turner SM, Galovski TE. Early abuse, psychiatric diagnoses and irritable bowel syndrome. Behav Res Ther 2002;40:289-298
54. Drossman DA, Li Z, Leserman J, Toomey TC, Hu YJ. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology 1996;110:999-1007
55. Emmanuel AV, Kamm MA. Gastrointestinal mucosal laser Doppler blood flow to measure gut innervation-reproducibility and effect of food, diurnal variation, age, body size, menstrual cycle and gender. Gastroenterology 1997;112:A729
56. Emmanuel AV, Kamm MA, Mason H. Direct evidence of psychological state affecting extrinsic innervation of the gut-laser Doppler flowmetry to measure mucosal blood flow. Gastroenterology 1997;112:A728
57. Emmanuel AV, Kamm MA. Laser Doppler measurement of rectal mucosal blood flow. Gut 1999;45:64-69
58. Emmanuel AV, Kamm MA. Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease. Gut 2000;46:212-217
59. Emmanuel AV, Mason HJ, Kamm MA. Relationship between psychological state and level of activity of extrinsic gut innervation in patients with a functional gut disorder. Gut 2001;49:209-213
60. Wilhelmsen I. Brain-gut axis as example of the bio-psycho-social model. Gut 2000;(suppl IV)47:iv 5-iv 7
61. Mearin F, Cucala M, azpiroz F, Malagelada JR. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991;101:999-1006
62. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-293
63. Cervero F. Visceral hyperalgesia revisited. Lancet 2000;356:1127-1128
64. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001;121:526-535
65. Bouin M, Meunier P, Riberdy-Poitras M, Poitras P. Pain hypersensitivity in patients with functional gastrointestinal disorders: A gastrointestinal-specific defect or a general systemic condition? Dig Dis Sci 2001;46:2542-2548
66. Berstad A. Taday's therapy of functional gastrointestinal disorders-does it help? Eur J Surg 1998;(Suppl) 583:92-97
67. Hausken T, Svebak S, Wilhelmsen I, Haug TT, Olafsen K, Pettersson E, Hveem K, Berstal A. Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosom Med 1993;55:12-22
68. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to - A meal in functional dyspepsia. Gastroenterology 1998;115:1346-1352
69. Haug TT, Svebak S, Hausken T, Wilhelmsen I, Berstad A, Ursin H. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosom Med 1994;56:181-186
70. Ringel Y. Brain research in functional gastrointestinal disorders. J Clin Gastroenterol 2002;35:S23-25
71. Mertz H, Morgan V, Tanner G, Pickens D, Price R, Shyr Y, Kessler R. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000;118:842-848
72. Drossman DA. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med 1999;107(5A):41S-50S
73. Thompson WG, Gick M. Irritable bowel syndrome. Semin Gastrointest Dis 1996;7:217-229
74. Tanum L, Malt UF. A new pharmacological treatment of functional gastrointestinal disorder: A double-blind placebo-controlled study with mianserin. Scand J Gastroenterol 1996;31:318-325
75. Jackson IL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K. Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis. Am J Med 2000;108:65-72
76. O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999;48:980-990
77. Toner BB, Segal ZV, Emmott S, Myran D, Ali A, DiGasharro I, Stuckless N. Cognitive-behavioral group therapy for patients with irritable bowel syndrome. Int J Group Psychother 1998;48:215-243
78. Galovski TE, Blanchard EB. The treatment of irritable bowel syndrome with hypnotherapy. Appl Psychophysiol Biofeedback 1998; 23:219-232
79. Boyce P. Psychologic Therapies for Irritable bowel Syndrome. Curr Treat Options Gastroenterol 2001;4:323-331
80. Blanchard EB, Scharff L. Psychosocial aspects of assessment and treatment of irritable bowel syndrome in adults and recurrent abdominal pain in children. J Consult Chin Psychol 2002;70:725-738
81. Hamilton J, Guthrie E, Creed F, Thompson D, Tomenson B, Bennett R, Moriarty K, Stephens W, Liston R. A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000;119:661-669
82. Chiotakakou-faliakou E, Kamm MA, Roy AJ, Storrie JB, Turner IC. Biofeedback provides long term benefit for patients with intractable slow and normal transit constipation. Gut 1998;42:517-521
83. Emmanuel AV, Kamm MA. Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut 2001;49:214-219
84. Heymann-Monnikes I, Arnold R, Florin I, Herda C, Melfsen S, Monnikes H. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 2000;95:981-994
85. Wang WA, Pan GZ, Qian JM. Cognitive therapy for patients with refractory irritable bowel syndrome. Zhonghua Neike Zazhi 2002;41:156-159
86. Boyce P, Gilchrist J, Tally NJ, Rose D. Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: A pilot study. Aust N Z J Psychiatry 2000;34:300-309
87. Keefer L, Blanchard EB. The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: Results of a controlled treatment study. Behav Res Ther 2001;39:801-811
88. Talley NJ, Owen BK, Paterson K. Psychological treatments for irritable bowel syndrome: A critique of controlled treatment trials. Am J Gastroenterol 1996;91:277-286
89. Gruber AJ, Hudson JI, Pope HG Jr. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am 1996;19:351-369
90. Thompson WG. The treatment of irritable bowel syndrome. Alinent Pharmacol Ther 2002;16:1395-1406